changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Certain BTG products may not be available within the chosen location and indications may differ from your country's approved use.
For Medical questions regarding any BTG products, please contact email@example.com
“You have liver cancer”, can be a life altering experience and can start a cascade of emotions. By spending time researching treatment options for either yourself or a loved one, you are ensuring you will be receiving the best care available today based on individual needs.
TheraSphere<span style="color: #fff;">™</span> is a low toxicity, targeted liver cancer therapy that consists of millions of tiny glass beads containing radioactive yttrium-90. The glass beads - about the third of the width of a human hair – are delivered directly to the liver tumors.
This patient website includes details about what to expect from typical TheraSphere™ treatment activities and possible side effects. It also contains helpful information such a glossary and patient resources.<br />
Ask your doctor if TheraSphere™ is right for you.
Clinical Trials with TheraSphere™ Yttrium-90 Glass Microspheres.
Arizona Patients Successfully Receive th...
Recommended Cash Offer for BTG plc by Bo...
BTG plc: Interim Results 2018
OPTALYSE PE Results Presented at Society...
Healthcare Player BTG on lookout for acq...
NICE highlights potential role of TheraS...